- Home
- IRWD vs GDL Comparison
IRWD vs GDL Comparison
Compare IRWD & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- GDL
- Stock Information
- Founded
- IRWD 1998
- GDL 2006
- Country
- IRWD United States
- GDL United States
- Employees
- IRWD N/A
- GDL N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- GDL Investment Managers
- Sector
- IRWD Health Care
- GDL Finance
- Exchange
- IRWD Nasdaq
- GDL Nasdaq
- Market Cap
- IRWD 111.2M
- GDL 93.3M
- IPO Year
- IRWD 2010
- GDL N/A
- Fundamental
- Price
- IRWD $1.03
- GDL $8.37
- Analyst Decision
- IRWD Buy
- GDL
- Analyst Count
- IRWD 5
- GDL 0
- Target Price
- IRWD $4.94
- GDL N/A
- AVG Volume (30 Days)
- IRWD 1.5M
- GDL 11.2K
- Earning Date
- IRWD 08-07-2025
- GDL 01-01-0001
- Dividend Yield
- IRWD N/A
- GDL 6.02%
- EPS Growth
- IRWD N/A
- GDL N/A
- EPS
- IRWD N/A
- GDL N/A
- Revenue
- IRWD $308,519,000.00
- GDL N/A
- Revenue This Year
- IRWD N/A
- GDL N/A
- Revenue Next Year
- IRWD N/A
- GDL N/A
- P/E Ratio
- IRWD N/A
- GDL N/A
- Revenue Growth
- IRWD N/A
- GDL N/A
- 52 Week Low
- IRWD $0.53
- GDL $7.65
- 52 Week High
- IRWD $5.21
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- IRWD 63.45
- GDL 53.38
- Support Level
- IRWD $0.81
- GDL $8.24
- Resistance Level
- IRWD $1.16
- GDL $8.40
- Average True Range (ATR)
- IRWD 0.11
- GDL 0.07
- MACD
- IRWD 0.02
- GDL 0.00
- Stochastic Oscillator
- IRWD 70.45
- GDL 66.75
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.